Bernd Giebel,
Group Leader, Institute for Transfusion Medicine
Bernd Giebel studied biology at the University zu Köln and received his PhD in 1996 at the Institute for Developmental Biology in Köln. He runs a lab at the Institute for Transfusion Medicine at the University Hospital Essen. Since 1999 he works with human hematopoietic stem cells and started in 2009 to explore the therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Together with collaboration partners the group demonstrated the therapeutic potential of prepared MSC-EVs in a human GvHD-patient and in different animal models. It is the current goal to optimize the MSC-EV production and characterization process to efficiently translate MSC-EVs into the clinics.
B Giebel is the president of the German Society of Extracellular Vesicles (GSEV) and a co-chair of the exosome working group of the International Society of Gene and Cell Therapy (ISCT) and an active member of the International Society of Extracellular Vesicles (ISEV). Furthermore, he is part of the scientific advisory board of two SME companies, Innovex Therapeutics and Mursla LTD. In 2021 he became a founding director of Exosla LTD.
|
|
|
